Complement activation has been implicated as an inflammatory driver of neurodegeneration in retinal and brain pathologies. However, its involvement and influence of photoreceptor degeneration in retinitis pigmentosa (RP), an inherited, largely incurable blinding disease, is unclear. We discover that markedly upregulated retinal expression of multiple complement components coincided spatiotemporally with photoreceptor degeneration in both the rd10 mouse model and in human specimens of RP, with increased complement C3 expression and activation localizing to infiltrating microglia near photoreceptors. Genetic ablation of C3 in the rd10 background resulted in accelerated structural and functional photoreceptor degeneration and
Introduction
Retinitis pigmentosa (RP), an important blinding disease worldwide, consists of a genetically heterogenous group of inherited photoreceptor degenerations involving monogenic mutations in genes expressed predominantly in photoreceptors and retinal pigment epithelial (RPE) cells (1) . Although gene therapy for one specific causative mutation (RPE65) has recently gained approval (2) , broadly-applicable, efficacious treatment is still unavailable for most affected patients, who typically progress to legal blindness by 40 years of age, and to severe loss of peripheral and central vision by 60 years of age (3) . This unmet medical need underscores the need to understand general mechanisms that underlie the progressive loss of photoreceptors in order to discover therapies that can slow degeneration and preserve visual function. Clinical and laboratory studies of RP have revealed that in addition to the physiological changes occurring within mutation-bearing photoreceptors, the disease is characterized by non-cell autonomous neuroinflammatory changes in the retina; these changes include the presence of activated microglia (4) (5) (6) and the upregulation in inflammatory cytokine expression (7, 8) , which can influence the progression of photoreceptor degeneration (9) (10) (11) . However, the consequences of innate immune system activation in the retina in the context of photoreceptor degeneration, and the molecular and cellular mechanisms underlying its activation and effects, are not well understood.
Complement expression and activation constitute one important aspect of innate immune system activation in the CNS function and pathology, both in the retina and the brain. Although complement function is necessary for normal development of neural circuits through synaptic elimination (12, 13) , it has been implicated as an etiologic factor in neurodegeneration (14) . In the retina, polymorphisms in multiple complement-related genes have been associated with genetic risk for age-related macular degeneration (AMD) (15) , a disease featuring photoreceptor apoptosis and atrophy (16) , as well as complement-laden deposits and increased complement activation (17, 18) . Common to both RP and AMD is the presence of activated microglia that infiltrate into the photoreceptor layer in close proximity to degenerating photoreceptors on histopathological analyses (4, 19, 20) ; these microglia are also thought to be sources of complement and complement regulatory factors within the retina (21) (22) (23) . Although clinical investigations involving the inhibition of complement activation as a therapeutic objective have been initiated for the treatment of AMD (24), the adaptive functions vs. deleterious dysregulation of complement activation in retinal pathologies have not been clearly discerned nor have the underlying mechanisms of action linking complement and neurodegeneration been fully elucidated.
In the current study, we sought to understand the involvement of complement in photoreceptor degeneration by employing the well-characterized rd10 mouse model of RP (25) to investigate spatiotemporal patterns of complement activation occurring in the retina and to correlate these to ongoing photoreceptor degeneration and microglial activation. We investigated the function and consequences of complement activation by examining photoreceptor degeneration in rd10 mouse that were deficient for either C3, the central complement component, and CR3, the microglia-expressed receptor to iC3b, a product of C3 activation. We discovered that complement expression and activation in the retina were prominently activated by rd10-related degeneration; in particular, increased C3 expression was found primarily in infiltrating microglia, with a concurrent opsonization of degenerating photoreceptors by the C3 activation product, iC3b. The net effect of C3 activation appears to be adaptive, as genetic deletion of C3 resulted in accelerated photoreceptor degeneration, an effect 5 that was phenocopied with the genetic deletion of CR3. We found that this adaptive complement function related to the phagocytic clearance of apoptotic photoreceptors by microglia, which helped to promote homeostasis in the degenerating retina, and to limit collateral effects that induce further non-cell autonomous photoreceptor degeneration. While dysregulated inflammatory responses involving excessive complement and microglial activation are currently thought to predominantly exacerbate retinal degeneration, our findings here conversely highlight the adaptive functions of complement and microglia that serve to promote homeostasis and limit photoreceptor loss. These factors are likely consequential in the overall understanding of the adaptive vs. deleterious effects of neuroimmune activation in the CNS and require consideration in the design and interpretation of complement-targeted therapies for retinal diseases such as RP and AMD.
Results

Complement expression and activation coincide spatiotemporally with photoreceptor degeneration in retinitis pigmentosa
To address the potential contribution of local complement-mediated mechanisms to photoreceptor degeneration, we first investigated how complement expression varied spatiotemporally within the retina across the period of degeneration. We performed quantitative PCR to measure retinal mRNA levels of complement components, regulatory factors, and receptors during the highly stereotypical progression of photoreceptor degeneration in the rd10 mouse. We observed that relative to postnatal day (P) 16, a time point preceding the onset of rod degeneration, retinal levels of C3 mRNA was prominently upregulated beginning at P21, coinciding with the onset of rod degeneration, and was maintained at elevated levels (>10 fold) up to P60 (Fig. 1A, B) . Increases in mRNA levels for regulatory proteins in the alternative pathway, Cfb and Cfi, were similarly elevated in magnitude and timing, while those for Cfh and Cfd were smaller and occurred later, peaking at P45 (Fig. 1C) . Expression levels of complement receptors, Cd11b, a component of CR3, as well as C3ar, and C5ar, were elevated during rod degeneration (Fig. 1D ), as were components of the classical pathway, C1qa and C2 (Fig. 1E ).
Similar mRNA expression changes were not detected for these transcripts over the same developmental timepoints in wild type (C57BL6/J) retina during the first postnatal month (Fig.   S1 ). These findings reveal a prominent upregulation of multiple complement components that is induced locally in the retina upon the onset and progression of rd10-related degeneration.
To discover the retinal locus of complement molecule expression, we performed fluorescent in situ hybridization of C3 mRNA in rd10 retinal sections at timepoints across rod degeneration (P16 -P30). While intraretinal C3 expression was not significantly detected at P16, it emerged prominently at P21 within the degenerating outer nuclear photoreceptor layer (ONL) and was sustained up to P30 ( Fig. 2A) . C3 mRNA labeling colocalized predominantly with IBA1-immunopositive cells, which also expressed Cx3cr1 mRNA, indicating microglia infiltrating into the ONL during rd10 degeneration (6) likely constituted the primary source of C3 upregulation (Fig. 2B) . Immunopositivity for iC3b, the product of C3 cleavage, was detected in the ONL beginning at P21, localizing to photoreceptor nuclei (Fig. 2C) . Immunopositivity for CFB, the positive regulator of C3 activation, also colocalized with infiltrating IBA1+ cells in the ONL beginning at P21 (Fig. 2D ). These findings indicate that microglia infiltrating the ONL at the start of rod degeneration likely contribute to C3 expression, with resulting C3 activation occurring in close proximity to degenerating photoreceptors. Upregulated C3 expression within ONL-infiltrating microglia was similarly detected in histopathological specimens from human patients diagnosed with retinitis pigmentosa (RP), but absent in healthy, non-RP retinas (Fig.   S2 ). This indicates C3 upregulation as an inflammatory response in the context of inherited photoreceptor degenerations that is conserved across species.
Photoreceptor degeneration is accelerated with genetic deficiency for C3 in rd10 mice
To investigate whether C3 upregulation and activation constitute an adaptive mechanism or conversely a deleterious contribution to rd10-related photoreceptor degeneration, we crossed mice that were genetically ablated for the C3 gene into the rd10 background, creating within individual litters three genotypes containing both, one, or neither copies of the intact C3 gene: .rd10. Optical coherence tomographic (OCT) imaging of central retina at P16 prior to degeneration onset revealed no significant differences across all 3 genotypes in the general laminated structure of the retina or in the thicknesses of the overall retina or of the outer retinal layers (Fig. 3A, B (33, 34) , and Cxcl10, which influences microglial recruitment and debris clearance (35) . Gene ontogeny analyses using IPA Ingenuity found that shared DE genes at P24 featured in canonical pathways involving interferon regulatory factor signaling, neuroinflammation signaling, and pattern recognition receptor signaling (Fig. 5D ), and were associated with functions of increased neuronal and retinal degeneration, and decreased phagocyte activation and chemotaxis (Fig. 5E ). These findings indicate a common molecular pattern of inflammatory changes between C3-and CR3-deficiency that appear influential to regulating the activation and phagocytic/clearance.
Microglial phagocytosis of apoptotic photoreceptors is regulated by a C3-CR3 dependent mechanism
As microglial responses in pathological situations can modulate the rate of neurodegeneration, we investigated how C3-and CR3-deficiency influences microglial morphology and physiology in the rd10 retina. We examined microglia infiltrating the ONL of flat-mounted retinas from C3- As microglia in rd10-related degeneration can phagocytose both apoptotic and nonapoptotic photoreceptors, enabling clearance of dead cells and phagoptosis of living cells respectively (6), we examined the relative phagocytosis of these targets by microglia in the contexts of C3-and CR3-deficiency (Fig. 6F) . We found that the proportion of ONL microglia engaged in photoreceptor phagocytosis (containing one or more photoreceptor-containing phagosomes) was significantly decreased in C3 6G ). This decreased ability of C3-and CR3-deficient microglia to phagocytose apoptotic photoreceptors also resulted in an increased proportion of TUNEL+ photoreceptors that were left uninternalized in these genotypes (Fig. 6H ).
To confirm that C3-CR3 expression and interaction involving microglia directly regulate microglial phagocytic capacity, we isolated retinal microglia from C3 +/+ , CR3 +/+ .rd10, C3 
C3-and CR3-deficiency in the rd10 retina are associated with increased microglial neurotoxicity
To further explore the relationship between decreased microglial phagocytic clearance and increased photoreceptor degeneration with C3-and CR3-deficiency in the rd10 retina, we examined the ability of retinal microglia cultured from different genotypes of mice to exert neurotoxic effects on photoreceptors. Retinal microglia were isolated from P24 animals from wild type (C57BL6), C3+/+, CR3+/+.rd10, C3-/-.rd10, and CR3-/-.rd10 animals and allowed to condition serum-free media for 48 hours, which was then exposed to cultured 661W
photoreceptors. While conditioned media from C3+/+, CR3+/+.rd10 microglia decreased photoreceptor viability more than microglia from wild type non-degenerating retina, conditioned media from C3-or CR3-deficient rd10 retinas exerted the largest negative impact of photoreceptor viability (Fig. 7A) . Consistent with previous studies in which phagocytosis of apoptotic cells was linked with the downregulation of microglial activation and proinflammatory cytokine expression (36, 37), we found that protein levels of the cytokines TNFα, IL6, IL12, and IL33, were elevated in C3-and/or CR3-deficient rd10 retinas (Fig. 7B ). These findings indicate that while increased non-clearance and accumulation of apoptotic photoreceptors owing to decreased microglial phagocytosis may directly compromise the survival of nearby photoreceptors (38) , phagocytosis-deficient microglia can exert more neurotoxic effects on nearby photoreceptors, possibly via increased proinflammatory cytokine secretion.
Taken together, our study examining the role of complement in photoreceptor degeneration demonstrates an adaptive, complement-dependent, mechanism that is induced upon the onset of degenerative changes that facilitates the clearance apoptotic photoreceptors by infiltrating retinal microglia expressing C3 and CR3. The inhibition of this mechanism can reduce adaptive homeostasis to retinal pathology, inducing further deleterious alterations in the immune environment of the retina, that results in an acceleration of structural and functional degeneration.
Discussion
We discover here that RP-related photoreceptor degeneration, which arises from a cellautonomous photoreceptor gene mutation, induces a marked, non-cell autonomous, We discover here that part of the adaptive complement response to rod photoreceptor degeneration resulting from the rod-specific Pde6b mutation in the rd10 mouse model involves:
(1) the increased expression of C3, primarily by microglia infiltrating the photoreceptor layer at the outset of rod degeneration, (2) the opsonization of photoreceptors by iC3b, the activation product of C3, and (3) the phagocytic clearance of photoreceptors by infiltrating microglia via the CR3 receptor (Fig. S8) . In the retina, while the expression of C3 has been attributed to astrocytes (47) and RPE cells (49) when autofluorescent microglia, which presumably had phagocytosed photoreceptors, were pharmacologically depleted, degeneration was increased (57). We discover here in the rd10 retina that both C3 and CR3 participate in facilitating microglial phagocytosis of apoptotic photoreceptors; when either of these factors are deficient, decreased microglial phagocytosis was accompanied by increased accumulation of apoptotic cells, increased proinflammatory cytokine expression, and accelerated degeneration. These current and previous findings indicate that microglia employ a variety of molecular mechanisms to contribute to a balance between the adaptive clearance of apoptotic cells and the maladaptive phagoptosis of stressed but still living photoreceptors.
We found here that apoptotic cell accumulation, occurring here from a deficiency in C3-CR3 mediated microglial clearance, was associated with compromised survival of the remaining photoreceptors. The mechanism for this deleterious influence may arise from apoptotic photoreceptors releasing TNFα to induce non-cell-autonomous apoptosis in adjacent cells (58, 59), and/or increased proinflammatory effects of greater microglial activation, which may be triggered by signals released from the lysis of uncleared cells (60) and decreased downregulatory effects on microglial activation that typically occur after the successful phagocytosis of apoptotic cells (61) . We found support for a microglia-mediated deleterious influence as phagocytosisdeficient microglia cultured from C3-or CR3-ablated retinas demonstrated greater in vitro neurotoxicity to photoreceptors, an effect that was also associated with increased retinal levels of proinflammatory cytokines, including TNFα and IL6. This altered inflammatory milieu in the rd10 ONL may carry over beyond the period of rod death to secondarily impact cone death as was observed here, underscoring a broad contribution to complement-mediated apoptotic cell clearance to promoting long-term homeostasis in the degenerating retina.
One of the limitations of our study is that relatively early onset of degeneration in the rd10 retina had largely precluded the use of "cell-fate" mapping to differentiate endogenous microglia from potentially infiltrating monocytes, as we had previously done (62) . Despite this, we have used the term "microglia" to refer to the IBA1+ myeloid cells infiltrating the ONL and engaging in C3 upregulation and phagocytosis of photoreceptors. While studies of other genetic mouse models of photoreceptor degeneration have described the infiltration of CCR2+ monocytes into the subretinal space (20, 63), we had previously found that in the rd10 retina, these infiltrating macrophages appeared to be largely confined to the subretinal space and did not engage photoreceptors via dynamic phagocytosis as observed for CCR2-negative microglia within the ONL (6) . In other models of photoreceptor degeneration involving more acute injury, endogenous microglia, as tracked by cell-fate mapping, were found to infiltrate from the inner to the outer retina, while monocyte-derived macrophages enter into the inner retina via the retinal circulation; however these cells were not found substantially in the ONL to contribute to photoreceptor phagocytosis (62, 64) . While we are unable to completely rule out possible contributions from monocyte-derived macrophages to phagocytic clearance, overall available evidence indicates endogenous infiltrating microglia to be the predominant cell type involved.
As a result of studies associating increased complement activation with retinal degeneration and implicating complement-related genes as conferring genetic risks of age-related macular degeneration (AMD) (15, 65) , there is much current interest in strategies to inhibit 
Materials and Methods
Study design
The objective of our study was to determine the presence of complement activation in RP retinas and its influence on photoreceptor degeneration by studying a well-characterized RP mouse model (rd10) and human histopathological RP specimens. We used a combination of rtPCR, in situ hybridization, and immunohistochemical techniques to quantitate and localize mRNA and protein expression of complement components across the period of degeneration in the RP context. Because we found the central complement component C3 and its activation product, iC3b, to be prominently upregulated in the locus of degeneration in association with infiltrating microglia, we examined the roles of C3 and its microglia-expressed receptor CR3, in degeneration by examining rd10 animals that had been crossed into C3-or CR3-deficient backgrounds, using histological techniques and in vivo imaging and electrophysiological assays.
Changes in microglial physiology, as a result of C3-or CR3-deficiency, were also studied using paraformaldehyde, the retinas were dissected out and sectioned into 12m-thick cryostat sections. Eye tissue was collected under applicable regulations and guidelines with proper consent, protection of human subjects, and donor confidentiality.
Detection and localization of mRNA in retinal sections using multiplex in situ hybridization
For in situ hybridization of mRNA probes, frozen retinal tissues from murine and human eyes were sectioned at 12µm. Resulting sections were heated at 65C for 1 h, immersed in 4% paraformaldehyde for 15 minutes, and then in RNAscope® Protease III for 30 minutes at 40C.
In situ detection of mouse C3 (Mm-C3, #417841), mouse Cx3cr1 (Mm-Cx3cr1, #314221), and human C3 (Hs-C3, #430701) was performed using the RNAscope® Multiplex Fluorescent Reagent Kit v2 (Advanced Cell Diagnostics) according to the manufacturer's specifications.
Fluorescent signal amplification was performed with TSA® Plus fluorescein or Cy5 (1:1500, NEL760001KT, PerkinElmer).
In vivo optical coherence tomographic (OCT) imaging of mouse retina
Mice were anesthetized with intraperitoneal ketamine (90 mg/kg) and xylazine (8 mg/kg) and their pupils were dilated. Retinal structure was assessed using an OCT imaging system (Bioptigen; InVivoVue Software). Volume scans consisting of 100 horizontal sequential B-scans (consisting of 1000 A-scans each), spanning an en-face retinal area of 1.4mm by 1.4mm centered on the optic nerve were captured. Retinal thickness measurements were performed in each retinal quadrant at a radial distance of 0.7mm from the optic nerve using the manufacturer's software (Bioptigen; Diver) and averaged for each eye. Total retinal thickness, defined as the distance from the nerve fiber layer to the RPE, and outer retinal thickness, defined as the distance from the outer plexiform layer to the inner surface of the RPE, were measured from OCT images after manual retinal segmentation. The presence of shallow retinal detachments was manually evaluated in the entire scan field and scored as present or absent.
Statistical analysis
Statistical analyses were performed using Prism 7.0d (GraphPad). For comparisons involving two data columns, t tests (paired or unpaired) or nonparametric tests (Mann-Whitney) were used, depending on whether the data followed a Gaussian distribution as determined by normality tests. A normality test (D'Agostino and Pearson) was used to analyze the distribution of all datasets. For comparisons involving three or more data columns, a one-way ANOVA (with Dunnett's multiple-comparisons test) was used if the data followed a Gaussian distribution and a nonparametric Kruskal-Wallis test (withDunn's multiple-comparisons test) was used if it did not. Datasets from different genotypes were compared using a two-way ANOVA. Fig. S1 . Complement components, regulatory factors, and receptors are not markedly increased in expression in wild type retina across the ages of P16 to P30. mRNA expression levels of complement molecules in the rd10 retina from P16 to P60 were analyzed with RT-PCR.
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Expression of C3 was markedly upregulated from P21 and sustained until P60. (C) Analysis of mRNA expression of complement regulatory factors showed early and marked upregulation for Cfb and Cfi, but not for Cfh or Cfd. (D) mRNA levels for receptors of complement components, including Cd11b, C3ar, and C5ar, as well as for components of the classical complement pathway, C1qa and C2, were also significantly increased during photoreceptor degeneration. mRNA expression levels at different time-points were normalized to levels at P16, p values for comparisons relative to levels at P16 were indicated as: *, p<0.05; **, p<0.01; ***, p<0.001; 1-way ANOVA with Dunnett's multiple comparison test, n = 4 animals per time-point. -/-.rd10, and (4) CR3 -/-.rd10, and allowed to condition serum-free media for 48 hours. Direct neurotoxicity of microglia was assessed in vitro by exposing microglia-conditioned media to 661W photoreceptors for 12 h and evaluating photoreceptor survival using a MTT assay. Microglia from degenerating rd10 retinas of all 3 genotypes was associated with a neurotoxic effect than microglia from C57BL6 retinas. Phagocytosis-deficient microglia from C3 -/-.rd10, and CR3 -/-.rd10 retinas in addition were associated with significantly greater neurotoxicity than C3 .rd10 microglia. p values were derived from a 1-way ANOVA with Tukey's multiple comparisons test, n = 14 and 3 replicates per condition for the neurotoxicity assay (A) and cytokine level assay respectively.
